| Dr Lina Judith Bautista, MD | |
|
2800 Providence Dr, Anchorage, AK 99508-4623 | |
| (907) 269-7152 | |
| (907) 269-7251 |
| Full Name | Dr Lina Judith Bautista |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Child & Adolescent Psychiatry |
| Location | 2800 Providence Dr, Anchorage, Alaska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982625596 | NPI | - | NPPES |
| MD02182 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | 2785 (Alaska) | Primary |
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467547265 PECOS PAC ID: 2163335746 Enrollment ID: O20031110000525 |
News Archive
The ALS Association is pleased to announce the award of $326,662 in research funds to expand ongoing natural history studies in order to further understand the most common genetic cause of ALS, in preparation for clinical trials in those whose disease is affected by this gene.
Improving job prospects for people in economically depressed parts of the United States is unlikely to help curb the opioid epidemic, according to a study by researchers at Princeton University. On the other hand, opioid use may actually help some women - but not men - stay in the labor force when they would otherwise leave because of chronic pain.
The U.S. Food and Drug Administration today approved the Optimizer Smart system for treating patients with chronic, moderate-to-severe heart failure who are not suited for treatment with other heart failure devices such as cardiac resynchronization therapy to restore a normal timing pattern of the heartbeat.
Even caregivers whose children receive the first dose of influenza vaccine may be vaccine hesitant and have inaccurate beliefs regarding influenza vaccine and disease, according to a new American Academy of Pediatrics Pediatric Research in Office Settings study that was a collaboration between investigators at Children's Hospital of Philadelphia, Columbia University Irving Medical Center, and the AAP.
QuatRx Pharmaceuticals Company, a privately-held biopharmaceutical company, today announced positive efficacy results from the second of two patient cohorts in the second pivotal Phase 3 study for Ophena(TM) (ospemifene tablets), the company's investigational compound in development for the treatment of postmenopausal vulvovaginal atrophy (VVA).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lina Judith Bautista, MD 2800 Providence Dr, Anchorage, AK 99508-4623 Ph: (907) 269-7152 | Dr Lina Judith Bautista, MD 2800 Providence Dr, Anchorage, AK 99508-4623 Ph: (907) 269-7152 |
News Archive
The ALS Association is pleased to announce the award of $326,662 in research funds to expand ongoing natural history studies in order to further understand the most common genetic cause of ALS, in preparation for clinical trials in those whose disease is affected by this gene.
Improving job prospects for people in economically depressed parts of the United States is unlikely to help curb the opioid epidemic, according to a study by researchers at Princeton University. On the other hand, opioid use may actually help some women - but not men - stay in the labor force when they would otherwise leave because of chronic pain.
The U.S. Food and Drug Administration today approved the Optimizer Smart system for treating patients with chronic, moderate-to-severe heart failure who are not suited for treatment with other heart failure devices such as cardiac resynchronization therapy to restore a normal timing pattern of the heartbeat.
Even caregivers whose children receive the first dose of influenza vaccine may be vaccine hesitant and have inaccurate beliefs regarding influenza vaccine and disease, according to a new American Academy of Pediatrics Pediatric Research in Office Settings study that was a collaboration between investigators at Children's Hospital of Philadelphia, Columbia University Irving Medical Center, and the AAP.
QuatRx Pharmaceuticals Company, a privately-held biopharmaceutical company, today announced positive efficacy results from the second of two patient cohorts in the second pivotal Phase 3 study for Ophena(TM) (ospemifene tablets), the company's investigational compound in development for the treatment of postmenopausal vulvovaginal atrophy (VVA).
› Verified 4 days ago
Daniel Gregory Allen, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 673 Medical Group, Jb Elmendorf-richardson, Anchorage, AK 99506 Phone: 907-580-2181 | |
Robert D Wald, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2605 Denali St, Ste 203, Anchorage, AK 99503 Phone: 907-677-9253 Fax: 907-272-1553 | |
Dr. Sheila Joyce Clark, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 207 E Northern Lights Blvd, Ste 111, Anchorage, AK 99503 Phone: 907-272-1892 Fax: 907-272-0962 | |
Dr. David Michael Henzler, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1100 E Dimond Blvd, Anchorage, AK 99515 Phone: 907-565-6000 Fax: 907-565-6001 | |
Dr. Karen Jackman, M.D Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1675 C St, Suite 117, Anchorage, AK 99501 Phone: 907-274-8281 Fax: 907-274-4055 | |
Dr. Steven Edward Koehl, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 5955 Zeamer Ave, Anchorage, AK 99506 Phone: 907-580-2181 | |
Dr. Cathleen E Marshall, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3340 Providence Dr Ste A565, Anchorage, AK 99508 Phone: 907-212-2321 Fax: 907-212-8499 |